Having established a robust in vivo model, we determined that within CD133+ SCC cells the tumor-initiating capacity was 1 cell per 400 cells, which represented approximately 1% of the tumor cells, compared with unsorted SCC cells which was 1 cell per 1 × 106 cells (40). Here, PROM1 is linked to neoplasm.